Lidocaine, Prilocaine Topical Cream 2.5-2.5pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Lidocaine, Prilocaine: Topical cream (2.5-2.5%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Lidocaine/Prilocaine Cream
Drug Image file default-drug-image.png
Lidocaine/Prilocaine Cream
Drug Image file default-drug-image.png
Lidocaine/Prilocaine Cream
Drug Image file default-drug-image.png
Lidocaine/Prilocaine Cream
Drug Image file default-drug-image.png
Lidocaine/Prilocaine Cream

What is this Medicine?

LIDOCAINE; PRILOCAINE (LYE doe kane; PRIL oh kane) is a topical anesthetic that causes loss of feeling in the skin and surrounding tissues. It is used to numb the skin before procedures or injections.

CVS Pharmacy Patient Statistics for Lidocaine, Prilocaine: Topical cream(2.5-2.5%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Lidocaine/Prilocaine 2.5%-2.5% Topical Cream

NDC: 503830667
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Topical Anesthesia, Local Anesthesia

Sometimes used for but not FDA approved for the following conditions:
Premature Ejaculation

Lidocaine/Prilocaine 2.5%-2.5% Topical Cream

Reported Side Effects for Lidocaine/Prilocaine 2.5%-2.5% Topical Cream

Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Arthropathy Incidence:
0.3%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
0.3%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
2.0%*
Severity: MILD
Onset: RAPID
Swelling Incidence:
6.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
21.0-30.0%*
Severity: MODERATE
Onset: EARLY
Pale Skin Incidence:
37.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lidocaine, Prilocaine

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.